Shorter hormone therapy may be enough for many men with prostate cancer

	Prostate Cancer
	The latest prostate cancer news from News Medical

	Shorter hormone therapy may be enough for many men with prostate cancer A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first 9 to 12 months.

	Landmark prostate cancer screening trial launches in the UK The first men have been invited to take part in Prostate Cancer UK's TRANSFORM trial, kicking off the biggest prostate cancer screening study in a generation.

			Single-port robotic surgery transforms cancer care at NYU Langone Hospital—Long Island After enduring seven prior abdominal surgeries, 64-year-old Joy Monetti from Islip was no stranger to painful procedures and lengthy recoveries.

			Evidence links severe gum disease to erectile dysfunction and broader men’s health risks A healthy mouth is also key to a healthy body, as gum disease has been linked to non-communicable diseases such as diabetes, cardiovascular disease, rheumatoid arthritis and Alzheimer's.

	Study uncovers promising therapeutic strategies against neuroendocrine prostate cancer A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

	Age impacts systemic therapy outcomes in metastatic prostate cancer Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says one more factor should be considered – chronological age.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025